(b)(6).Pma/510(k)#: p100022/s001.The incident meets criteria for fda mdr reporting based on the reporting malfunction precedence established for this product family for stent fracture regardless of patient outcome.The ziv6-35-125-6.0-120-ptx stent of lot number c777373 was implanted in the patient, therefore is not available for evaluation.With the information provided a document based investigation was carried out.It was confirmed that no imaging would be available to support the complaint investigation.It is possible that difficult patient anatomy or patient¿s lifestyle could have contributed to this event.However, as no imaging was provided and due to limited information, a definitive root cause cannot be determined and no other comments can be made.As no imaging was available there is no evidence to suggest that stent fracture did not occur.Therefore the complaint is confirmed based on customer testimony.It may be noted that, stent strut fracture is a known potential adverse event associated with the placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.No adverse effects to the patient have been reported and no medical/surgical intervention was performed due to this occurrence.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
|